Levoketoconazole
Levoketoconazole is one of two enantiomeric forms of racemic ketoconazole that strongly inhibits multiple steroidogenic enzymes and is used for the symptomatic treatment of endogenous Cushing’s syndrome.
Systematic Name
1-[4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one
Brand Name(S)
Recorlev
Therapeutic Category
Cushing syndrome
Suitable Formulations
Solid
Approvals
USDMF Exclusive For US Market
EU-WC